CD98hc是生物治疗药物向大脑输送的目标
Kylie S Chew1, Robert C Wells1, Arash Moshkforoush1
1Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Nature communications
|August 19, 2023
概括
研究人员设计了一种针对CD98重链 (CD98hc) 的新型血脑屏障 (BBB) 运输车辆,以增强大脑药物输送. 与现有方法相比,这个新平台显示了更好的动力学和生物分布.
科学领域:
- 神经科学是一个神经科学.
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 血脑屏障 (BBB) 严重限制了治疗药物的系统性输送到大脑.
- 针对特定的运输商是克服BBB限制的关键策略.
研究的目的:
- 设计和描述一款针对CD98重链 (CD98hc) 的新型BBB运输车辆.
- 评估这个新平台的药理动力学和生物分布特性.
主要方法:
- 针对CD98hc的抗体运输车辆的工程 (ATVCD98hc).
- 在人性化的CD98hc敲入小鼠和Cynomolgus子中评估ATVCD98hc.
- 通过Fc突变和Fab变异调节大脑帕伦基马生物分布.
主要成果:
- 与转移林受体向平台相比,ATVCD98hc表现出较慢和更长时间的脑传递动力学.
- 通过改变Fc参与和标结合价值,成功调节了大脑生物分布特征.
- 观察到有利的运动,生物分布和安全性质.
结论:
- CD98hc代表了一个模块化的BBB运输车辆平台的可行目标.
- 开发的TVCD98hc平台与现有的BBB传输系统相比,具有明显的优势.
- 这个平台有望改善大脑药物输送应用程序.
更多相关视频
08:37Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
Published on: December 22, 2020
3.7K
06:41Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery
Published on: January 31, 2017
11.0K
相关概念视频
Drug Delivery: Parenteral Route
612
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
612
The Blood-brain Barrier
47.5K
Overview
47.5K
